Literature DB >> 29182350

Using the 4 Pillars to increase vaccination among high-risk adults: who benefits?

Mary Patricia Nowalk1, Krissy K Moehling, Song Zhang, Jonathan M Raviotta, Richard K Zimmerman, Chyongchiou J Lin.   

Abstract

OBJECTIVES: To compare changes in vaccination rates (pneumococcal polysaccharide vaccine [PPSV]; tetanus, diphtheria, and pertussis [Tdap] vaccine; and influenza vaccine) among high-risk adults following an intervention (June 1, 2013, to January 31, 2015) that used the 4 Pillars Practice Transformation Program (4 Pillars Program). STUDY
DESIGN: Post hoc analysis of data from a randomized controlled cluster trial.
METHODS: Eighteen primary care practices received staff education, guidance for using the 4 Pillars Program, and support for a practice immunization champion. Paired t tests were used to compare vaccination rates separately for those with diabetes, chronic lung or chronic heart disease, or other high-risk conditions. Student's t tests were used to compare vaccination rates across high-risk conditions. Generalized estimating equation modeling was used to determine the likelihood of vaccination.
RESULTS: Based on International Classification of Diseases, Ninth Revision, Clinical Modification codes, 4737 patients aged 18 to 64 years were identified as having diabetes (n = 1999), chronic heart disease (n = 658), chronic lung disease (n = 1682), or another high-risk condition (n = 764). PPSV uptake increased by 12.2 percentage points (PP), Tdap vaccination increased by 11.4 PP, and influenza vaccination increased by 4.8 PP. In regression analyses, patients with diabetes (odds ratio [OR], 2.2; 95% CI, 1.80-2.73), chronic lung disease (OR, 1.50; 95% CI, 1.21-1.87), or chronic heart disease (OR, 1.32; 95% CI, 1.02-1.71) were more likely to receive PPSV than those without the respective high-risk condition. Those with diabetes (OR, 1.14; 95% CI, 1.01-1.28) or chronic lung disease (OR, 1.14; 95% CI, 1.01-1.30) were more likely to receive an influenza vaccine than those without the respective condition. The likelihood of Tdap vaccination was not significantly associated with any of the chronic conditions tested.
CONCLUSIONS: An intervention including the 4 Pillars Program was associated with significant increases in vaccination of high-risk adults. However, the overall uptake of recommended vaccines for those with high-risk conditions remained below national goals.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29182350      PMCID: PMC6166239     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  22 in total

1.  Network 13 partnership to improve the influenza, pneumococcal pneumonia, and hepatitis B vaccination rates among dialysis patients.

Authors:  Linda Duval; Cheryl George; Nellie Hedrick; Sandra Woodruff; Myra A Kleinpeter
Journal:  Adv Perit Dial       Date:  2011

Review 2.  Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review.

Authors:  Serigne M Ndiaye; David P Hopkins; Abigail M Shefer; Alan R Hinman; Peter A Briss; Lance Rodewald; Bayo Willis
Journal:  Am J Prev Med       Date:  2005-06       Impact factor: 5.043

3.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-10-12       Impact factor: 17.586

Review 4.  Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis.

Authors:  Darren Lau; Jia Hu; Sumit R Majumdar; Dale A Storie; Sandra E Rees; Jeffrey A Johnson
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

5.  Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Authors:  Katrina Kretsinger; Karen R Broder; Margaret M Cortese; M Patricia Joyce; Ismael Ortega-Sanchez; Grace M Lee; Tejpratap Tiwari; Amanda C Cohn; Barbara A Slade; John K Iskander; Christina M Mijalski; Kristin H Brown; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-12-15

6.  Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.

Authors:  Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; David K Kim; Lisa A Grohskopf; Tamara Pilishvili; Tami H Skoff; Noele P Nelson; Rafael Harpaz; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Carolyn B Bridges
Journal:  MMWR Surveill Summ       Date:  2016-02-05

7.  Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.

Authors:  Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; Carolyn B Bridges; David K Kim; Tamara Pilishvili; Craig M Hales; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-06       Impact factor: 17.586

8.  Rates of pneumococcal disease in adults with chronic medical conditions.

Authors:  Kimberly M Shea; John Edelsberg; Derek Weycker; Raymond A Farkouh; David R Strutton; Stephen I Pelton
Journal:  Open Forum Infect Dis       Date:  2014-05-27       Impact factor: 3.835

9.  Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice.

Authors:  Laura J Dexter; M Dawn Teare; Matthew Dexter; A Niroshan Siriwardena; Robert C Read
Journal:  BMJ Open       Date:  2012-05-11       Impact factor: 2.692

10.  Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Sonja J Olsen; Joseph S Bresee; Karen R Broder; Ruth A Karron
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-08-07       Impact factor: 17.586

View more
  2 in total

1.  The need for vaccination in adults with chronic (noncommunicable) diseases in India - lessons from around the world.

Authors:  Agam Vora; Alberta Di Pasquale; Shafi Kolhapure; Ashish Agrawal; Someya Agrawal
Journal:  Hum Vaccin Immunother       Date:  2022-04-13       Impact factor: 4.526

2.  An overview of implementing an evidence based program to increase HPV vaccination in HIV community clinics.

Authors:  Jessica Wells; James L Klosky; Yuan Liu; Theresa Wicklin Gillespie
Journal:  BMC Public Health       Date:  2022-09-07       Impact factor: 4.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.